Clinical Trials and Research Recruiting in New South Wales

Date Added

Description

Physical Activity and Fatigue in Early Multiple Sclerosis (MS) (BEGIN)

The purpose of this observational study is to obtain a survey on physical activity in patients who for the first time have experienced symptoms which indicate a high risk for developing multiple sclerosis (MS) and in patients with recently diagnosed MS, and to obtain information on factors potentially influencing the patients' level of activity.

Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis (SONIC)

A clinical study to evaluate the efficacy and safety of solifenacin in patients with bladder symptoms due to spinal cord injury or multiple sclerosis

Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting. (ReNew)

This observational multicentric study is planned to assess the tolerability of Rebif New Formulation in an Australian clinical setting by the incidence of injection site reactions (ISRs). The study will allow the comparison of tolerability data with historical data for both Rebif New and classic formulations, and will do so by using the same pre- specified preferred terms of treatment emergent adverse events as done in historical studies. In addition, the study will analyse whether interaction(s) with a nurse impacts tolerability and the impact of Rebif New Formulation on the patient's Quality of Life.

ACT-128800 in Relapsing-remitting Multiple Sclerosis

This study will assess the efficacy, safety, and tolerability of ACT-128800 in patients with relapsing-remitting multiple sclerosis.

Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)

SB-683699 is an oral medication that is thought to reduce the number of active white blood cells entering the brain; these white blood cells are part of the disease process for MS. This study will look at whether different doses of SB-683699 are effective and safe in patients with relapsing remitting MS.

The Australian MS Longitudinal Study

The Australian MS Longitudinal Study (AMSLS) is critical to understanding the full effects of MS on Australian society, including the individual and overall community cost. The data from the AMSLS provides a regularly updated evidence base for a number of stakeholders including health professionals, scientific and applied scientists and a specialist workforce servicing the MS community in an effort to improve understanding of MS and service delivery. Any Australian resident diagnosed with MS after June 2002 is eligible to join the Study. For more information about the AMSLS and how to participate visit the MSRA website.

Teenagers’ adjustment to their parent’s MS

Researchers at the University of Southampton (UK) are carrying out an anonymous research survey to help us understand factors which may help adolescents adjust to their parents’ MS and those made adjustment more difficult. Teenagers (13-18 years old) are asked to complete an online survey. The completion of the survey will take approximately 15 minutes.  If you are interested please read the attached information sheets or contact Angeliki Bogosian

To fill in the survey please read the attached information sheets and follow the link at the bottom of each page.

Information Sheet for Parents

Information Sheet for Teenagers

2009

A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis

View

2009

An examination of prospective memory in MS, employment difficulties, and early departure from work

View